CCL2 and chronic kidney disease: Our previous data demonstrated that exposure of endothelial cells to uremic plasma results in time- and CKD stage-dependent increases in expression of adhesion molecules, such as VCAM-1, and chemokines, such as MCP-1 and IL-8, which suggested a link between vascular activation, systemic inflammation, and uremic toxicity [4].